These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Presneill JJ; Harris T; Stewart AG; Cade JF; Wilson JW Am J Respir Crit Care Med; 2002 Jul; 166(2):138-43. PubMed ID: 12119223 [TBL] [Abstract][Full Text] [Related]
5. Short communication: Effect of granulocyte-macrophage colony-stimulating factor on neonatal calf peripheral blood neutrophil function in vitro. Roach HB; Brester JL; Abuelo A J Dairy Sci; 2020 Jan; 103(1):864-870. PubMed ID: 31733852 [TBL] [Abstract][Full Text] [Related]
6. Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial. Uyl-de Groot CA; Vellenga E; de Vries EG; Löwenberg B; Stoter GJ; Rutten FF Pharmacoeconomics; 1997 Sep; 12(3):351-60. PubMed ID: 10170460 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022 [TBL] [Abstract][Full Text] [Related]
8. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor. Kletter Y; Bleiberg I; Golde DW; Fabian I Eur J Haematol; 1989 Nov; 43(5):389-96. PubMed ID: 2482194 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF. Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585 [TBL] [Abstract][Full Text] [Related]
10. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro. Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243 [TBL] [Abstract][Full Text] [Related]
11. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma. Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669 [TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Advani R; Chao NJ; Horning SJ; Blume KG; Ahn DK; Lamborn KR; Fleming NC; Bonnem EM; Greenberg PL Ann Intern Med; 1992 Feb; 116(3):183-9. PubMed ID: 1345803 [TBL] [Abstract][Full Text] [Related]
13. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096 [TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte-macrophage colony-stimulating factor on neutrophil function in idiopathic bronchiectasis. Ruchaud-Sparagano MH; Gertig H; Hester KL; Macfarlane JG; Corris PA; Simpson AJ; De Soyza A Respirology; 2013 Nov; 18(8):1230-5. PubMed ID: 23730995 [TBL] [Abstract][Full Text] [Related]
15. HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection. Fu J; Sha BE; Thomas LL J Acquir Immune Defic Syndr; 2011 Jan; 56(1):16-25. PubMed ID: 20975570 [TBL] [Abstract][Full Text] [Related]
16. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Baldwin GC; Gasson JC; Quan SG; Fleischmann J; Weisbart R; Oette D; Mitsuyasu RT; Golde DW Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2763-6. PubMed ID: 3282238 [TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis. Bo L; Wang F; Zhu J; Li J; Deng X Crit Care; 2011; 15(1):R58. PubMed ID: 21310070 [TBL] [Abstract][Full Text] [Related]
19. Role of leucocyte integrins in phagocyte responses to granulocyte-macrophage colony stimulating factor (GM-CSF): in vitro and in vivo studies on leucocyte adhesion deficiency neutrophils. Yong K; Addison IE; Johnson B; Webster AD; Linch DC Br J Haematol; 1991 Feb; 77(2):150-7. PubMed ID: 1672257 [TBL] [Abstract][Full Text] [Related]